4 medicines held by Deciphera Pharmaceuticals (Netherlands) B.V. on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| QINLOCK 50 mg tablets EU/1/21/1569/001-002 |
Ripretinib | Deciphera Pharmaceuticals (Netherlands) B.V. | — |
| ROMVIMZA 14 mg hard capsules EU/1/25/1968/001 |
Vimseltinib | Deciphera Pharmaceuticals (Netherlands) B.V. | — |
| ROMVIMZA 20 mg hard capsules EU/1/25/1968/002 |
Vimseltinib | Deciphera Pharmaceuticals (Netherlands) B.V. | — |
| ROMVIMZA 30 mg hard capsules EU/1/25/1968/003 |
Vimseltinib | Deciphera Pharmaceuticals (Netherlands) B.V. | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 16 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.